Evidence-based guidelines for supportive care of patients with Ebola virus disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29054555.
- Also identified by DOI 10.1016/S0140-6736(17)31795-6 and PMC identifier 6636325.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The 2013-16 Ebola virus disease outbreak in west Africa was associated with unprecedented challenges in the provision of care to patients with Ebola virus disease, including absence of pre-existing isolation and treatment facilities, patients' reluctance to present for medical care, and limitations in the provision of supportive medical care. Case fatality rates in west Africa were initially greater than 70%, but decreased with improvements in supportive care. To inform optimal care in a future outbreak of Ebola virus disease, we employed the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology to develop evidence-based guidelines for the delivery of supportive care to patients admitted to Ebola treatment units. Key recommendations include administration of oral and, as necessary, intravenous hydration; systematic monitoring of vital signs and volume status; availability of key biochemical testing; adequate staffing ratios; and availability of analgesics, including opioids, for pain relief.
Medical subject headings
- Disease Outbreaks
- Evidence-Based Medicine
- Hemorrhagic Fever, Ebola
- Patient Acceptance of Health Care